FAR Integrated With Safety Act
Client Alert | less than 1 min read | 11.13.07
On November 7, 2007, the Federal Acquisition Regulatory Council issued an interim rule integrating the liability and litigation protections administered by DHS under the SAFETY Act with federal agency purchases of anti-terrorism technologies and services. Agencies now have standard procurement clauses to use when purchasing products and services for homeland defense, including clauses to allow the acceptance of offers contingent on the issuance of SAFETY Act designations or certifications and equitable adjustments for situations in which SAFETY Act coverage is denied after award.
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
